These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25133971)

  • 21. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
    Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
    Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer.
    Yin PT; Shah S; Pasquale NJ; Garbuzenko OB; Minko T; Lee KB
    Biomaterials; 2016 Mar; 81():46-57. PubMed ID: 26720500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Weak Link: Optimization of the Ligand-Nanoparticle Interface To Enhance Cancer Cell Targeting by Polymer Micelles.
    Wang J; Dzuricky M; Chilkoti A
    Nano Lett; 2017 Oct; 17(10):5995-6005. PubMed ID: 28853896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells.
    Surnar B; Sharma K; Jayakannan M
    Nanoscale; 2015 Nov; 7(42):17964-79. PubMed ID: 26465291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mean-field and linear regime approach to magnetic hyperthermia of core-shell nanoparticles: can tiny nanostructures fight cancer?
    Carrião MS; Bakuzis AF
    Nanoscale; 2016 Apr; 8(15):8363-77. PubMed ID: 27046437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational development of a cytotoxic peptide to trigger cell death.
    Boohaker RJ; Zhang G; Lee MW; Nemec KN; Santra S; Perez JM; Khaled AR
    Mol Pharm; 2012 Jul; 9(7):2080-93. PubMed ID: 22591113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
    Gu J; Chen X; Fang X; Sha X
    Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
    Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
    Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functionalized selenium nanoparticles for targeted siRNA delivery silence Derlin1 and promote antitumor efficacy against cervical cancer.
    Xia Y; Tang G; Wang C; Zhong J; Chen Y; Hua L; Li Y; Liu H; Zhu B
    Drug Deliv; 2020 Dec; 27(1):15-25. PubMed ID: 31830840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-assembled nanoparticles composed of glycol chitosan-dequalinium for mitochondria-targeted drug delivery.
    Mallick S; Song SJ; Bae Y; Choi JS
    Int J Biol Macromol; 2019 Jul; 132():451-460. PubMed ID: 30930268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
    Xu W; Ge P; Niu B; Zhang X; Liu J; Xie J
    J Colloid Interface Sci; 2018 Oct; 527():141-150. PubMed ID: 29787950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core-shell nanocarriers with high paclitaxel loading for passive and active targeting.
    Jin Z; Lv Y; Cao H; Yao J; Zhou J; He W; Yin L
    Sci Rep; 2016 Jun; 6():27559. PubMed ID: 27278751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming Chemoresistance in Cancer via Combined MicroRNA Therapeutics with Anticancer Drugs Using Multifunctional Magnetic Core-Shell Nanoparticles.
    Yin PT; Pongkulapa T; Cho HY; Han J; Pasquale NJ; Rabie H; Kim JH; Choi JW; Lee KB
    ACS Appl Mater Interfaces; 2018 Aug; 10(32):26954-26963. PubMed ID: 30028120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
    Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
    Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer.
    Wan X; Liu C; Lin Y; Fu J; Lu G; Lu Z
    Drug Deliv; 2019 Dec; 26(1):470-480. PubMed ID: 30957572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-responsive nanoparticle assembly from peptide amphiphiles for tumor targeting drug delivery.
    Chang C; Liang P; Chen L; Liu J; Chen S; Zheng G; Quan C
    J Biomater Sci Polym Ed; 2017 Sep; 28(13):1338-1350. PubMed ID: 28467173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable Amphipathic Peptide Hydrogels as Extended-Release System for Opioid Peptides.
    Martin C; Dumitrascuta M; Mannes M; Lantero A; Bucher D; Walker K; Van Wanseele Y; Oyen E; Hernot S; Van Eeckhaut A; Madder A; Hoogenboom R; Spetea M; Ballet S
    J Med Chem; 2018 Nov; 61(21):9784-9789. PubMed ID: 30351003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular delivery of peptide cargos using polyhydroxybutyrate based biodegradable nanoparticles: Studies on antitumor efficacy of BCL-2 converting peptide, NuBCP-9.
    Kapoor S; Gupta D; Kumar M; Sharma S; Gupta AK; Misro MM; Singh H
    Int J Pharm; 2016 Sep; 511(2):876-89. PubMed ID: 27492021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.